Your search returned 3 results.

Results
	1.	Phase I study of the humanised anti-EGFR monoclonal antibody matuzumab (EMD 72000) combined with gemcitabine in advanced pancreatic cancer. [electronic resource] by Graeven, U Kremer, B Südhoff, Th Killing, B Rojo, F Weber, D Tillner, J Unal, C Schmiegel, W Producer: 20060605 In: British journal of cancer vol. 94 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Intraperitoneal bevacizumab for control of malignant ascites due to advanced-stage gastrointestinal cancers: A multicentre double-blind, placebo-controlled phase II study - AIO SUP-0108. [electronic resource] by Jordan, K Luetkens, T Gog, C Killing, B Arnold, D Hinke, A Stahl, M Freier, W Rüssel, J Atanackovic, D Hegewisch-Becker, S Producer: 20170721 In: European journal of cancer (Oxford, England : 1990) vol. 63 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Quality of life assessment in patients with metastatic colorectal cancer receiving maintenance therapy after first-line induction treatment: a preplanned analysis of the phase III AIO KRK 0207 trial. [electronic resource] by Quidde, J Hegewisch-Becker, S Graeven, U Lerchenmüller, C A Killing, B Depenbusch, R Steffens, C-C Lange, T Dietrich, G Stoehlmacher, J Reinacher, A Tannapfel, A Trarbach, T Marschner, N Schmoll, H-J Hinke, A Al-Batran, S-E Arnold, D Producer: 20171226 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)